June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Discovery of imaging biomarkers for healthy aging and age-related macular degeneration using counterfactual generative adversarial networks
Author Affiliations & Notes
  • Martin Joseph Menten
    BioMedIA, Imperial College London, London, United Kingdom
    Institute for AI and Informatics in Medicine, Technische Universitat Munchen, Munich, Germany
  • Oliver Leingang
    Laboratory for Ophthalmic Image Analysis, Medizinische Universitat Wien, Vienna, Austria
  • Hrvoje Bogunovic
    Laboratory for Ophthalmic Image Analysis, Medizinische Universitat Wien, Vienna, Austria
    Christian Doppler Laboratory for Artificial Intelligence in Retina, Christian Doppler Forschungsgesellschaft, Vienna, Austria
  • Robbie Holland
    BioMedIA, Imperial College London, London, United Kingdom
  • Ahmed M Hagag
    Institute of Ophthalmology, University College London, London, United Kingdom
    Moorfields Eye Unit, National Institute for Health Research, London, United Kingdom
  • Rebecca Kaye
    Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom
  • Sophie Riedl
    Laboratory for Ophthalmic Image Analysis, Medizinische Universitat Wien, Vienna, Austria
  • Ghislaine Traber
    Institute of Molecular and Clinical Ophthalmology Basel, Basel, Switzerland
    Department of Ophthalmology, Universitat Basel, Basel, Switzerland
  • Lars Fritsche
    Department of Biostatistics, University of Michigan, Ann Arbor, Michigan, United States
  • Toby Prevost
    Nightingale-Saunders Clinical Trials & Epidemiology Unit, King's College London, London, United Kingdom
  • Hendrik P Scholl
    Institute of Molecular and Clinical Ophthalmology Basel, Basel, Switzerland
    Department of Ophthalmology, Universitat Basel, Basel, Switzerland
  • Ursula Schmidt-Erfurth
    Laboratory for Ophthalmic Image Analysis, Medizinische Universitat Wien, Vienna, Austria
  • Sobha Sivaprasad
    Institute of Ophthalmology, University College London, London, United Kingdom
    Moorfields Eye Unit, National Institute for Health Research, London, United Kingdom
  • Daniel Rueckert
    BioMedIA, Imperial College London, London, United Kingdom
    Institute for AI and Informatics in Medicine, Technische Universitat Munchen, Munich, Germany
  • Andrew J Lotery
    Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom
  • Footnotes
    Commercial Relationships   Martin Menten None; Oliver Leingang None; Hrvoje Bogunovic None; Robbie Holland None; Ahmed Hagag None; Rebecca Kaye None; Sophie Riedl None; Ghislaine Traber None; Lars Fritsche None; Toby Prevost None; Hendrik Scholl None; Ursula Schmidt-Erfurth None; Sobha Sivaprasad None; Daniel Rueckert None; Andrew Lotery None
  • Footnotes
    Support  Wellcome Trust Collaborative Award, “Deciphering AMD by deep phenotyping and machine learning (PINNACLE)”, ref. 210572/Z/18/Z.
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 3855. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Martin Joseph Menten, Oliver Leingang, Hrvoje Bogunovic, Robbie Holland, Ahmed M Hagag, Rebecca Kaye, Sophie Riedl, Ghislaine Traber, Lars Fritsche, Toby Prevost, Hendrik P Scholl, Ursula Schmidt-Erfurth, Sobha Sivaprasad, Daniel Rueckert, Andrew J Lotery; Discovery of imaging biomarkers for healthy aging and age-related macular degeneration using counterfactual generative adversarial networks. Invest. Ophthalmol. Vis. Sci. 2022;63(7):3855.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : There is a lack of clinically usable biomarkers for the diagnosis and prognosis of age-related macular degeneration (AMD). Visualizing the effect of healthy and pathological aging on the retina may aid the discovery of novel imaging biomarkers for AMD. To this end, we explore the use of deep learning to synthesize counterfactual OCT images that reflect hypothetical scenarios in which age, sex or disease stage of the scanned subject are changed while the subject’s identity remains fixed.

Methods : We developed a counterfactual generative adversarial network (GAN) that alters existing OCT images to visualize the retina at a different, operator-selectable age, sex or AMD disease stage. Two datasets, which have been curated for the PINNACLE study, were used for GAN training and validation: 175,869 OCT images of predominantly healthy participants in the UK Biobank population study and 57,875 images of AMD patients undergoing treatment at Southampton Eye Unit. The visual quality of the counterfactuals was quantified by conducting a Turing Test, in which five expert ophthalmologists were asked to distinguish between real and artificially generated OCT images. Additionally, we measured whether the generated images faithfully depict the counterfactual age and sex and preserve the subject identity by predicting these demographics using independently trained ResNet-50 neural networks.

Results : The generated counterfactuals were indistinguishable from real OCT images in most cases (Turing Test accuracy: 76.6%±18.4%). The GAN realistically modified image features associated with subject age and sex (correlation between counterfactual and predicted age: Pearson’s R of 0.86±0.02; agreement between counterfactual and predicted sex: 79.7%±5.8%), while preserving subject identity in 88.8%±6.4% of counterfactuals. Several observed retinal changes were linked to plausible biomarkers, such as thinning of retinal layers with aging or increase in drusen size with progressing AMD.

Conclusions : We have demonstrated the ability of GANs to generate realistic counterfactual OCT images, which can be used to visualize the individual course of retinal changes caused by healthy or pathological aging.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

 

Two representative examples of counterfactuals visualizing the effect of age, sex and disease progression.

Two representative examples of counterfactuals visualizing the effect of age, sex and disease progression.

 

Quantitative analysis of the GAN’s ability to model age and sex.

Quantitative analysis of the GAN’s ability to model age and sex.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×